St. John's Wort: more implications for cancer patients.
Patrick J
PJ
Mansky
Stephen E
SE
Straus
D000928:Antidepressive Agents / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000097:blood / Q000493:pharmacokinetics*; D000972:Antineoplastic Agents, Phytogenic / Q000493:pharmacokinetics; D002166:Camptothecin / Q000031:analogs & derivatives / Q000493:pharmacokinetics; D051544:Cytochrome P-450 CYP3A; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis / Q000187:drug effects / Q000378:metabolism*; D004790:Enzyme Induction / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000493:pharmacokinetics; D006801:Humans; D020902:Hypericum / Q000009:adverse effects*; D000077146:Irinotecan; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism*
D000928:Antidepressive Agents; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D004791:Enzyme Inhibitors; D000077146:Irinotecan; D003577:Cytochrome P-450 Enzyme System; D006899:Mixed Function Oxygenases; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D002166:Camptothecin